DEXCOM INC (DC4.DE) Fundamental Analysis & Valuation

FRA:DC4 • US2521311074

Current stock price

54.46 EUR
-3.76 (-6.46%)
Last:

This DC4.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DC4.DE Profitability Analysis

1.1 Basic Checks

  • DC4 had positive earnings in the past year.
  • DC4 had a positive operating cash flow in the past year.
  • In the past 5 years DC4 has always been profitable.
  • In the past 5 years DC4 always reported a positive cash flow from operatings.
DC4.DE Yearly Net Income VS EBIT VS OCF VS FCFDC4.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.19%, DC4 belongs to the top of the industry, outperforming 93.44% of the companies in the same industry.
  • DC4's Return On Equity of 30.46% is amongst the best of the industry. DC4 outperforms 96.72% of its industry peers.
  • DC4 has a Return On Invested Capital of 18.92%. This is amongst the best in the industry. DC4 outperforms 96.72% of its industry peers.
  • DC4 had an Average Return On Invested Capital over the past 3 years of 14.59%. This is above the industry average of 10.18%.
  • The 3 year average ROIC (14.59%) for DC4 is below the current ROIC(18.92%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.19%
ROE 30.46%
ROIC 18.92%
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
DC4.DE Yearly ROA, ROE, ROICDC4.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 17.94%, DC4 belongs to the top of the industry, outperforming 93.44% of the companies in the same industry.
  • DC4's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 21.55%, DC4 belongs to the top of the industry, outperforming 85.25% of the companies in the same industry.
  • DC4's Operating Margin has improved in the last couple of years.
  • DC4 has a Gross Margin of 62.09%. This is in the better half of the industry: DC4 outperforms 63.93% of its industry peers.
  • In the last couple of years the Gross Margin of DC4 has declined.
Industry RankSector Rank
OM 21.55%
PM (TTM) 17.94%
GM 62.09%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
DC4.DE Yearly Profit, Operating, Gross MarginsDC4.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DC4.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DC4 is creating value.
  • DC4 has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DC4 has about the same amount of shares outstanding.
  • DC4 has a better debt/assets ratio than last year.
DC4.DE Yearly Shares OutstandingDC4.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
DC4.DE Yearly Total Debt VS Total AssetsDC4.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 6.17 indicates that DC4 is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.17, DC4 belongs to the top of the industry, outperforming 88.52% of the companies in the same industry.
  • DC4 has a debt to FCF ratio of 1.20. This is a very positive value and a sign of high solvency as it would only need 1.20 years to pay back of all of its debts.
  • DC4 has a Debt to FCF ratio of 1.20. This is amongst the best in the industry. DC4 outperforms 85.25% of its industry peers.
  • A Debt/Equity ratio of 0.47 indicates that DC4 is not too dependend on debt financing.
  • DC4 has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: DC4 outperforms 47.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.2
Altman-Z 6.17
ROIC/WACC1.86
WACC10.16%
DC4.DE Yearly LT Debt VS Equity VS FCFDC4.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • DC4 has a Current Ratio of 1.88. This is a normal value and indicates that DC4 is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.88, DC4 perfoms like the industry average, outperforming 59.02% of the companies in the same industry.
  • DC4 has a Quick Ratio of 1.59. This is a normal value and indicates that DC4 is financially healthy and should not expect problems in meeting its short term obligations.
  • DC4 has a better Quick ratio (1.59) than 72.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.59
DC4.DE Yearly Current Assets VS Current LiabilitesDC4.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. DC4.DE Growth Analysis

3.1 Past

  • DC4 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
  • The Earnings Per Share has been growing by 19.29% on average over the past years. This is quite good.
  • DC4 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.60%.
  • Measured over the past years, DC4 shows a quite strong growth in Revenue. The Revenue has been growing by 19.33% on average per year.
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%

3.2 Future

  • DC4 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.71% yearly.
  • DC4 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.94% yearly.
EPS Next Y36.69%
EPS Next 2Y27.75%
EPS Next 3Y24.99%
EPS Next 5Y21.71%
Revenue Next Year12.64%
Revenue Next 2Y12.51%
Revenue Next 3Y12.32%
Revenue Next 5Y11.94%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DC4.DE Yearly Revenue VS EstimatesDC4.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
DC4.DE Yearly EPS VS EstimatesDC4.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. DC4.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 33.62, DC4 can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as DC4.
  • When comparing the Price/Earnings ratio of DC4 to the average of the S&P500 Index (24.75), we can say DC4 is valued slightly more expensively.
  • A Price/Forward Earnings ratio of 24.60 indicates a rather expensive valuation of DC4.
  • DC4's Price/Forward Earnings ratio is in line with the industry average.
  • DC4's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 33.62
Fwd PE 24.6
DC4.DE Price Earnings VS Forward Price EarningsDC4.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as DC4.
  • 72.13% of the companies in the same industry are more expensive than DC4, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.34
EV/EBITDA 17.74
DC4.DE Per share dataDC4.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • DC4's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DC4 has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as DC4's earnings are expected to grow with 24.99% in the coming years.
PEG (NY)0.92
PEG (5Y)1.74
EPS Next 2Y27.75%
EPS Next 3Y24.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DC4.DE Dividend Analysis

5.1 Amount

  • DC4 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DC4.DE Fundamentals: All Metrics, Ratios and Statistics

DEXCOM INC

FRA:DC4 (3/30/2026, 7:00:00 PM)

54.46

-3.76 (-6.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-23
Inst Owners100.29%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap20.96B
Revenue(TTM)4.66B
Net Income(TTM)836.30M
Analysts84.32
Price Target76 (39.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.4%
Min EPS beat(2)-32.12%
Max EPS beat(2)5.32%
EPS beat(4)2
Avg EPS beat(4)-6.03%
Min EPS beat(4)-32.12%
Max EPS beat(4)6.77%
EPS beat(8)5
Avg EPS beat(8)-1.11%
EPS beat(12)9
Avg EPS beat(12)9.15%
EPS beat(16)11
Avg EPS beat(16)5.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.9%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-1.02%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)6
Avg Revenue beat(16)-0.53%
PT rev (1m)1.27%
PT rev (3m)2.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.31%
EPS NY rev (1m)0.69%
EPS NY rev (3m)0.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE 33.62
Fwd PE 24.6
P/S 5.16
P/FCF 22.34
P/OCF 16.71
P/B 8.77
P/tB 9.08
EV/EBITDA 17.74
EPS(TTM)1.62
EY2.97%
EPS(NY)2.21
Fwd EY4.07%
FCF(TTM)2.44
FCFY4.48%
OCF(TTM)3.26
OCFY5.99%
SpS10.55
BVpS6.21
TBVpS6
PEG (NY)0.92
PEG (5Y)1.74
Graham Number15.05
Profitability
Industry RankSector Rank
ROA 13.19%
ROE 30.46%
ROCE 23.93%
ROIC 18.92%
ROICexc 36.12%
ROICexgc 37.75%
OM 21.55%
PM (TTM) 17.94%
GM 62.09%
FCFM 23.11%
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
ROICexc(3y)37.89%
ROICexc(5y)31.72%
ROICexgc(3y)41.79%
ROICexgc(5y)35.48%
ROCE(3y)18.46%
ROCE(5y)14.75%
ROICexgc growth 3Y1.89%
ROICexgc growth 5Y6.96%
ROICexc growth 3Y7.33%
ROICexc growth 5Y6.44%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.2
Debt/EBITDA 1.03
Cap/Depr 144.36%
Cap/Sales 7.8%
Interest Coverage 88.12
Cash Conversion 114.67%
Profit Quality 128.81%
Current Ratio 1.88
Quick Ratio 1.59
Altman-Z 6.17
F-Score8
WACC10.16%
ROIC/WACC1.86
Cap/Depr(3y)145.46%
Cap/Depr(5y)210.39%
Cap/Sales(3y)7.74%
Cap/Sales(5y)10.33%
Profit Quality(3y)110.93%
Profit Quality(5y)89.33%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
EPS Next Y36.69%
EPS Next 2Y27.75%
EPS Next 3Y24.99%
EPS Next 5Y21.71%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%
Revenue Next Year12.64%
Revenue Next 2Y12.51%
Revenue Next 3Y12.32%
Revenue Next 5Y11.94%
EBIT growth 1Y53.73%
EBIT growth 3Y35.36%
EBIT growth 5Y25.41%
EBIT Next Year68.67%
EBIT Next 3Y32.44%
EBIT Next 5Y25.77%
FCF growth 1Y70.79%
FCF growth 3Y52.34%
FCF growth 5Y31.25%
OCF growth 1Y45.6%
OCF growth 3Y29.1%
OCF growth 5Y24.81%

DEXCOM INC / DC4.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DEXCOM INC (DC4.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DC4.DE.


What is the valuation status for DC4 stock?

ChartMill assigns a valuation rating of 4 / 10 to DEXCOM INC (DC4.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DEXCOM INC?

DEXCOM INC (DC4.DE) has a profitability rating of 8 / 10.


How financially healthy is DEXCOM INC?

The financial health rating of DEXCOM INC (DC4.DE) is 7 / 10.


Can you provide the expected EPS growth for DC4 stock?

The Earnings per Share (EPS) of DEXCOM INC (DC4.DE) is expected to grow by 36.69% in the next year.